glp-1 kidney Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection Frontiers | GLP-1 Receptor Agonists

For individuals significantly above 250 pounds, extended protocols of 16-20 weeks rather than higher daily doses often produce better outcomes

A dose taken with imperfect timing is always better than a dose not taken at all

The preclinical literature has described effects across multiple pathways, and mechanistic claims are better framed as a family of related observations rather than a settled mechanism

More extensive lateral ND (levels IIV) is considered in patients with MEN2A and familial MTC in cases of tumors greater than 1 cm or central LN metastasis [6]

Underestimating duty cycle: Even short peaks can matter if repeated frequentlypay attention to how often loads occur, not just their length

If semaglutide gets approved, it could give us doctors another way to help millions of people